Elevance Health, Inc. (NYSE: ELV) last traded at $412.70, up 2.93% on the session. The quote above updates while this page is open; the figures below are drawn from Elevance Health, Inc.’s own filings and are restated only when a new one is published.
Elevance Health, Inc. trades on NYSE under the ticker ELV. Its market capitalisation is $89.50 billion.
Valuation measures for Elevance Health, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $89.50B |
|---|---|
| Enterprise value | $160.69B |
| P/E ratio | 18.27 |
| Price / sales | 0.45 |
| Price / book | 1.99 |
| Beta | 0.34 |
Trailing-twelve-month figures tagged in Elevance Health, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $201.11B |
|---|---|
| Net income (TTM) | $4.96B |
| EPS (TTM) | $22.59 |
| Gross margin | 89.13% |
| Operating margin | 2.71% |
| Return on equity | 11.05% |
| Cash | $10.23B |
Range and volume for ELV over the past 52 weeks.
| 52-week high | $436.24 |
|---|---|
| 52-week low | $274.84 |
| Volume | 2.08M |
| Average volume | 1.20M |
| Previous close | $400.94 |
Dividend history for Elevance Health, Inc. over the trailing twelve months.
| Dividend yield | 1.66% |
|---|---|
| Dividend per share (TTM) | $6.87 |
| Payout ratio | 30.41% |
Invest a chosen dollar amount in Elevance Health, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ELV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.